← All organizations
Highest phase reached
Phase 4
First clinical trial
Oct 1, 2004Last known activity
Jun 30, 2025
Timeline
1980s
- Jan 1, 1984
The TIMI Study Group— Founded
Drugs by trial phase (18 distinct, 15 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (6 own, 0 via acquisition)
Phase 2 (8 own, 0 via acquisition)
Indications
Recent trials (15)
- NCT07028749CollaboratorPhase 2Jun 30, 2025
- NCT05492500CollaboratorPhase 2Sep 26, 2022
- NCT04755283CollaboratorPhase 2Feb 2, 2021
- NCT04363697Lead sponsorPhase 4Jun 15, 2020
- NCT04409834Lead sponsorPhase 4May 31, 2020
- NCT03705234CollaboratorPhase 3Oct 30, 2018
- NCT02145468CollaboratorPhase 3Jun 3, 2014
- NCT01730534CollaboratorPhase 3Apr 25, 2013
- NCT01235351Lead sponsorPhase 2Oct 1, 2010
- NCT01000727CollaboratorPhase 3Dec 1, 2009
- NCT00781391CollaboratorPhase 3Nov 1, 2008
- NCT00409578CollaboratorPhase 2Feb 1, 2007
- NCT00357968CollaboratorPhase 2Aug 1, 2006
- NCT00116012CollaboratorPhase 2Jun 1, 2005
- NCT00099788CollaboratorPhase 3Oct 1, 2004
Details
- Founded
- Boston, MA, US Jan 1, 1984
- Last known activity
- Jun 30, 2025